Journal article icon

Journal article

Predicting prostate cancer many years before diagnosis: how and why?

Abstract:

Evidence of reduced prostate cancer mortality from randomized trials in Europe supports early detection of prostate cancer with prostate-specific antigen (PSA). Yet PSA screening has generated considerable controversy: it is far from clear that the benefits outweigh risks, in terms of overdiagnosis and overtreatment. One way to shift the ratio of benefits to harm is to focus on men at highest risk, who have more to benefit than average. Neither family history nor any of the currently identifi...

Expand abstract

Actions


Access Document


Publisher copy:
10.1007/s00345-011-0795-8

Authors


Vickers, AJ More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Surgical Sciences
Journal:
World journal of urology
Volume:
30
Issue:
2
Pages:
131-135
Publication date:
2012-04-05
DOI:
EISSN:
1433-8726
ISSN:
0724-4983
URN:
uuid:b8a9ba30-a784-4922-a8fa-1ae21dff977c
Source identifiers:
365870
Local pid:
pubs:365870

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP